Lawyers claim the company "knew for decades" there was allegedly asbestos in its talc. But J&J insists its baby product was safe and stressed it "takes the issue of talc incredibly seriously" safety If the action goes ahead it is understood to be the first of its kind against the pharmaceutical giant in the UK.
Claimants include cancer patients, survivors, bereaved families and also some men.
A J&J spokesperson said the company has won the "vast majority" of trials in the US or won on appeal.
KP Law is leading the British case, representing around 2,000 people.
Esta historia es de la edición November 21, 2024 de Daily Express.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición November 21, 2024 de Daily Express.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Pressure mounts on Ange as side fail to halt slump
AT LEAST it was only one this time, Ange.
ARNE'S ARMY MARCHING ON
Slot's boys stage fightback surge seven points clear to
No end to City slump after Haaland howler.
NDIAYE BRILLIANCE GIVES TOFFEES MASSIVE POINT
SWING BRIDGE
Fulham end long wait to win at Chelsea - and deserve it
WHITE HAS LITTLER No. 2 IN SIGHTS KP
'Diamond' used to beat Luke's grandad weekly
BAN'S THE MAN
O'Brien star snatches King George glory in a thriller
Ukraine 'must fight for right to join Nato'
VOLODYMYR Zelensky claims Ukraine's membership of Nato is possible, but Kyiv will have to campaign hard to persuade allies to make it happen.
Love and hate...it's a new decade of Call The Midwife
RACISM, civil unrest and romance brings the new series of Call The Midwife into a new decade.
'We'll not let you hound out hunt'
PEOPLE line the streets to show their support for rural sports at traditional Boxing Day hunts as Labour pledges a crackdown.
How diabetes drug could help Alzheimer's patients
OZEMPIC could be key to reducing Alzheimer's disease and slowing the progression to dementia, researchers believe.
